You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

5-aza-2'deoxycytidine

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Buffalo

Active, not recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Aldesleukin
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 3, 2022

Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia With

Active, not recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +7 more
  • Duarte, California
  • +10 more
Jul 2, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

Withdrawn
  • Castration Levels of Testosterone
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 31, 2021

Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute

Recruiting
  • Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2021

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Alvocidib Hydrochloride, Decitabine,

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Alvocidib Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2020

Acute Myeloid Leukemia Trial (Camrelizumab(SHR-1210), Decitabine)

Unknown status
  • Acute Myeloid Leukemia
  • (no location specified)
Apr 16, 2020

Recurrent Ependymoma Trial in Houston (5-Azacytidine (5-AZA) group 1, 5-Azacytidine (5-AZA) group 2, 5-Azacytidine (5-AZA) group

Recruiting
  • Recurrent Ependymoma
  • 5-Azacytidine (5-AZA) group 1
  • +2 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Aug 17, 2022

Thrombocytopenia, Hematologic Diseases Trial in Suzhou (Decitabine, rhTPO, Conventional Treatment)

Completed
Has Results
  • Thrombocytopenia
  • Hematologic Diseases
  • Suzhou, Jiangsu, China
    The First affiliated Hospital of SooChow University
Apr 27, 2020

Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Chronic Myelogenous Leukemia
  • decitabine (5-aza-2'deoxycytidine)
  • Duarte, California
  • +7 more
Jan 13, 2020

Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)

Completed
  • Neoplasms
  • FdCyd + THU
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States (Cytarabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Brewer, Maine
  • +8 more
Jun 18, 2021

Acute Myeloid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Buffalo

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 16, 2020

Tumors, Solid Tumors Trial run by the NCI (TdCyd)

Suspended
  • Neoplasms
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 6, 2022

MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)

Recruiting
  • Myelodysplastic Syndromes
  • MDS/MPN Crossover Syndromes
  • Cleveland, Ohio
    Cleveland Medical Center, University Hospitals Seidman Cancer Ce
Aug 10, 2022

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +4 more
Sep 14, 2021

MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

Recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Lymphoma, T-Cell Trial in Charlottesville (Durvalumab, Pralatrexate, Romidepsin)

Recruiting
  • Lymphoma, T-Cell
  • Charlottesville, Virginia
    University of Virginia
Mar 16, 2022

Mixed Phenotype Acute Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Completed
Has Results
  • Mixed Phenotype Acute Leukemia
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 21, 2020

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in

Completed
Has Results
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +11 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Nov 13, 2019

Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Total-Body Irradiation
  • +5 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022

Melanoma, Melanoma, Uveal, Head Neck Cancer Trial in Rotterdam (Adoptive therapy with autologous MC2 TCR T cells)

Recruiting
  • Melanoma
  • +2 more
  • Adoptive therapy with autologous MC2 TCR T cells
  • Rotterdam, Netherlands
    Erasmus Medical Center
Jun 1, 2022

Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, FLT3 Tyrosine Kinase Domain Point

Terminated
Has Results
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 17, 2019

Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in Houston (Decitabine, Valproic Acid)

Completed
Has Results
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 2, 2019

Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Leipzig, Germany
    Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023